Articles with "patients mds" as a keyword



Photo from wikipedia

Iron overload in patients with myelodysplastic syndromes: An updated overview

Sign Up to like & get
recommendations!
Published in 2018 at "Cancer"

DOI: 10.1002/cncr.31550

Abstract: Myelodysplastic syndromes (MDS) encompass a heterogeneous group of clonal hematopoietic stem cell disorders characterized by a broad clinical spectrum related to ineffective hematopoiesis leading to unilineage or multilineage cytopenias, with a high propensity for transformation… read more here.

Keywords: overload patients; myelodysplastic syndromes; patients mds; iron overload ... See more keywords
Photo by lunarts from unsplash

Circulating HMGB1 is increased in myelodysplastic syndrome but not in other bone marrow failure syndromes: proof-of-concept cross-sectional study

Sign Up to like & get
recommendations!
Published in 2022 at "Therapeutic Advances in Hematology"

DOI: 10.1177/20406207221125990

Abstract: Background: Myelodysplastic syndrome (MDS) is associated with persistent immune activation. High mobility group box-1 (HMGB1) is a ubiquitous, functionally diverse, non-histone intranuclear protein. During acute and chronic inflammatory states, HMGB1 is actively released by inflammatory… read more here.

Keywords: myelodysplastic syndrome; circulating hmgb1; iqr; hmgb1 ... See more keywords
Photo from wikipedia

WT1 mRNA Expression in the Peripheral Blood of Patients with MDS Yields Additional Prognostic Information within the IPSS-R Risk Categories "Very Low", "Low" and "Intermediate"

Sign Up to like & get
recommendations!
Published in 2018 at "Blood"

DOI: 10.1182/blood-2018-99-113524

Abstract: Introduction: The revised version of the International Prognostic Scoring System, (IPSS-R), is an accepted standard for assessing the prognosis of patients with MDS. Its usefulness may be further improved by integrating molecular findings. However, such… read more here.

Keywords: risk; patients mds; ipss; expression ... See more keywords
Photo from wikipedia

Real-World Application of Molecular Genetic Sequencing in the Management of Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes: The Wisconsin Experience

Sign Up to like & get
recommendations!
Published in 2019 at "Blood"

DOI: 10.1182/blood-2019-123676

Abstract: Background: Next-generation sequencing (NGS) technologies have led to the discovery of recurrently-mutated genes in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). These mutations have proven useful in diagnosis, prognostication, and prediction of treatment response… read more here.

Keywords: risk; aml patients; molecular data; patients mds ... See more keywords
Photo by sharonmccutcheon from unsplash

Sleep Disturbance Among Patients with Myelodysplastic Syndromes and Acute Leukemia

Sign Up to like & get
recommendations!
Published in 2019 at "Blood"

DOI: 10.1182/blood-2019-125147

Abstract: BACKGROUND: Most patients with myelodysplastic syndromes (MDS) describe difficulty sleeping (Luskin et al Br J Haem 2017) and sleep disturbance is a likely contributor to the fatigue experienced by patients with MDS and acute leukemia.… read more here.

Keywords: acute leukemia; patients mds; consultancy; research funding ... See more keywords
Photo from archive.org

First Cytogenetic Profile of Omani Patients with de novo Myelodysplastic Syndromes: Comparison with data from Asia, Africa, Europe and North and South America.

Sign Up to like & get
recommendations!
Published in 2017 at "Sultan Qaboos University medical journal"

DOI: 10.18295/squmj.2017.17.03.005

Abstract: Clonal cytogenetic abnormalities have been reported among 30-80% of patients with myelodysplastic syndromes (MDS); however, 20-70% of patients with MDS show a normal karyotype that may nevertheless harbour a cryptic genetic alteration. Earlier reports have… read more here.

Keywords: profile omani; myelodysplastic syndromes; patients mds; omani patients ... See more keywords
Photo from wikipedia

Myelodysplastic Syndromes with Bone Marrow Fibrosis: An Update

Sign Up to like & get
recommendations!
Published in 2022 at "Annals of Laboratory Medicine"

DOI: 10.3343/alm.2022.42.3.299

Abstract: Myelodysplastic syndrome (MDS) is a diverse hematological malignancy with a wide spectrum of presentations and implications. Treatment strategies for patients with MDS heavily rely on prognostic scoring systems, such as the revised international prognostic scoring… read more here.

Keywords: syndromes bone; bone marrow; myelodysplastic syndromes; patients mds ... See more keywords